The Psychedelic Report : Navigating Setbacks: The Future of Psychedelic Medicine
SHOW NOTES
In this episode, Dr. Dave Rabin engages in a thought-provoking conversation with Skippy Mesirow. They delve into the evolving landscape of psychedelic medicine, discussing recent setbacks in the FDA's decision regarding MDMA-assisted therapy and the implications for the broader psychedelic community. Skippy shares his journey as a facilitator in the psychedelic space, offering insights from his work in Colorado's movement and innovative approaches in Aspen. Together, they discuss the vital role of community, compassion, and collaboration in advancing therapies, reflect on the healing and creative energy of Burning Man, and emphasize the importance of unity among advocates for decriminalization and legalization.
Tune in for an inspiring call to action and valuable insights from two dedicated leaders in the field.
Tune in for an inspiring call to action and valuable insights from two dedicated leaders in the field.
The Psychedelic Report
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr. Dave brings you the latest news and answers your questions to share perspectives from the front lines of this exciting movement.
LISTEN ON YOUR FAVORITE APP
